United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

United Therapeutics (UTHR) announced full enrollment of the TETON 1 study evaluating the use of Tyvaso or treprostinil, inhalation solution or ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

United Therapeutics said the FDA has cleared it to begin the first clinical trial testing whether organs from gene-edited ...

Kingswood Wealth Advisors LLC bought a new position in shares of United Therapeutics Co. (NASDAQ:UTHR – Free Report) during ...

The research offers hope to tens of thousands of patients with kidney failure who are on a long waiting list for an organ ...

The U.S. Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants ...

Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their ...

The US Food and Drug Administration approved clinical trials that will transplant organs from genetically modified pigs into ...